16 research outputs found

    Factors associated with HR≥70 bpm.

    No full text
    <p>BMI, body mass index; CAD, coronary artery disease; CCS, Canadian Cardiovascular Society; CHF, congestive heart failure; CI, confidence interval; COPD, chronic obstructive pulmonary disease; HR, heart rate; OR, odds.</p

    Antithrombotic therapy in patients with coronary artery disease and atrial fibrillation with increasing CHA<sub>2</sub>DS<sub>2</sub>-VASc score.

    No full text
    <p>Any antiplatelet therapy alone (single or dual) is therefore: <sup>a</sup> 1,178 (52.8%), <sup>b</sup> 130 (69.5%), <sup>c</sup> 542 (56.4%), <sup>d</sup> 505 (46.9%). Abbreviations: AP, antiplatelet; OAC, oral anticoagulant.</p

    Geographic distribution of patients in CLARIFY and use of oral antithrombotic therapy.

    No full text
    <p>No adjustment for baseline differences in the populations from different regions.</p><p>Abbreviation: AF, atrial fibrillation.</p><p>Geographic distribution of patients in CLARIFY and use of oral antithrombotic therapy.</p

    Distribution of HR for patients with versus without beta-blocker use.

    No full text
    <p>The vertical lines represent the minimum and maximum values. The box represents the lower (25<sup>th</sup> percentile) and upper (75<sup>th</sup> percentile) quartiles. Within the box, the vertical line is the median and the diamond the mean. Values>1.5 times the interquartile range were considered outliers and are shown as individual circles.</p
    corecore